Genmab — Maj 2016
-
Vi drøftede for nogle dage siden om Empliciti havde problemer med sin Orphan Designation. Sagen er nu afgjort: COMP anbefaler at Empliciti får frataget sin OD. Til gengæld bevarer Darzalex sin. http://www.ema.europa.eu/docs/en_GB/document_library/Committee_meeting_report/2016/04/WC500205413.pdf side 3
-
Tak Bulder.
-
Hvad sker der? Genmab i +

-
det er noget uforståeligt - US klarer sig skidt og USD ligger rekordlavt. Vi burde få tæsk, men har åbenbart en stærk case...
-
http://uniqueconsult.dk/2244/ Job i Genmab
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
god dag